Public Offering in Connection with Listing and Strengthening of the Capital Base
First written in FY2018-Q3. 19 of 20 entries say "Advanced", first in FY2018. Latest entry: FY2026.
25 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Between 1 March 2026 and 30 April 2026, the exercise of share acquisition rights increased the total number of issued shares by 5,600 and increased stated capital and capital reserves by ¥117 thousand each.」
The exercise of share acquisition rights before the filing date resulted in the additional issuance of 5,600 shares and increases in stated capital and capital reserves. - FY2026-H1AdvancedAnnual report
「1 March 2025–31 August 2025 (Note): 3,600 12,796,595 75 60,201 75 1,100,388」
The exercise of share acquisition rights resulted in the issuance of 3,600 shares during the interim accounting period and increased stated capital and capital reserves by ¥75 thousand each. - FY2025AdvancedAnnual report
「1 March 2024–28 February 2025 (Note 1): 2,000 12,792,995 42 60,126 42 1,100,312」
The exercise of share acquisition rights resulted in the additional issuance of 2,000 shares and increased stated capital and capital reserves by ¥42 thousand each. - FY2024-Q1AdvancedAnnual report
「1 March 2023–31 May 2023 (Note): 6,800 12,786,995 142 1,181,246 142 1,100,186」
The exercise of share acquisition rights resulted in the issuance of 6,800 shares and increased stated capital and capital reserves by ¥142 thousand each. - FY2023AdvancedAnnual report
「5 July 2022 11,324 12,780,195 4,999 1,181,103 4,999 1,100,043」
The issuance of restricted stock compensation and other transactions increased the number of issued shares to 12,780,195 and stated capital to ¥1,181 million. - FY2022-Q3AdvancedAnnual report
「During the cumulative third-quarter period under review, the issuance of new shares through the exercise of share acquisition rights and other transactions increased stated capital and capital surplus by ¥261.060 million each.」
The exercise of share acquisition rights and other transactions resulted in increases of ¥261.060 million each in stated capital and capital surplus during the cumulative third-quarter period under review. - FY2022-Q2AdvancedAnnual report
「During the cumulative second-quarter period under review, the issuance of new shares through the exercise of share acquisition rights and other transactions increased stated capital and capital surplus by ¥260.599 million each.」
The exercise of share acquisition rights and other transactions increased stated capital and capital surplus by ¥260.599 million each, expanding the capital base. - FY2022-Q1AdvancedAnnual report
「During the first quarter of the current fiscal year, the stock acquisition rights attached to bonds with stock acquisition rights subject to adjustment clauses for the exercise price and other instruments were exercised as follows.」
During the first quarter, 4,806 share acquisition rights were exercised, 480,600 shares were delivered and ¥506.189 million was raised. All exercises of the eighth series of share acquisition rights had been completed by 12 April 2021. - FY2021AdvancedAnnual report
「During the fiscal year under review, the share acquisition rights relating to bonds with share acquisition rights subject to adjustment clauses for the exercise price and other instruments were exercised as follows.」
Under the eighth series of share acquisition rights, 1,089,400 shares were delivered and ¥1,089.570 million was raised during the fiscal year under review. Exercises before the filing date are also stated, indicating progress in capital raising. - FY2021-Q3AdvancedAnnual report
「During the third quarter under review, the share acquisition rights relating to bonds with share acquisition rights subject to adjustment clauses for the exercise price and other instruments were exercised as follows.」
During the third quarter, 7,888 share acquisition rights were exercised, 788,800 shares were delivered and ¥812.119 million was raised. Capital raising through the exercise of share acquisition rights made substantial progress, increasing stated capital and capital reserves by ¥408.833 million each. - FY2021-Q2AdvancedAnnual report
「The company will strengthen its financial base through this fund raising and invest the funds in expanding revenue from the consulting and solutions businesses and in the growth of the innovation business, with the aim of expanding its operations.」
The company has implemented fund raising through the issuance of the eighth series of share acquisition rights by third-party allotment and has specified its policy of allocating the funds to strengthening its financial base and investing in the growth of each business. - FY2021-Q1AdvancedAnnual report
「1 March 2020–31 May 2020: 25,600 10,942,000 261 365,176 261 284,116.」
The exercise of share acquisition rights resulted in the issuance of 25,600 shares during the first quarter and increased stated capital and capital reserves by ¥261 thousand each. - FY2020AdvancedAnnual report
「1 March 2019–29 February 2020: 185,600 10,916,400 3,042 364,914 3,042 283,854.」
The exercise of share acquisition rights during the fiscal year resulted in the issuance of 185,600 shares and increases in the total number of issued shares, stated capital and capital reserves. - FY2020-Q3AdvancedAnnual report
「1 September 2019–30 November 2019: 80,000 10,858,800 1,680 364,082 1,680 283,022. Between 1 December 2019 and 31 December 2019, the exercise of share acquisition rights increased the total number of issued shares by 44,000 shares and increased stated capital and capital reserves by ¥648 thousand each.」
The exercise of share acquisition rights during the third quarter resulted in the issuance of 80,000 shares, followed by the issuance of an additional 44,000 shares in the month before filing. Stated capital and capital reserves also increased. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of share acquisition rights from March through May 2019 increased the number of issued shares by 27,600 and stated capital and capital reserves by ¥303 thousand each, with a further increase of 20,400 shares in June, according to the filing. - FY2019AdvancedAnnual report
「1 May 2018–28 February 2019: 800,800 10,730,800 8,934 361,872 8,934 280,812. Between 1 March 2019 and 30 April 2019, the exercise of share acquisition rights increased the total number of issued shares by 25,200 shares and increased stated capital and capital reserves by ¥253 thousand each.」
The exercise of share acquisition rights during the fiscal year increased the number of issued shares, stated capital and capital reserves, and additional exercises occurred by the filing date. - FY2019-Q3AdvancedAnnual report
「1 September 2018–30 November 2018: 11,600 10,262,000 211 357,278 211 276,218. Between 1 December 2018 and 31 December 2018, the exercise of share acquisition rights increased the total number of issued shares by 430,800 shares and increased stated capital and capital reserves by ¥3.970 million each.」
The company states that the exercise of share acquisition rights during the quarter increased the number of issued shares by 11,600, with a further increase of 430,800 shares after the quarter-end, along with increases in stated capital and capital reserves. - FY2019-Q2AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The statement of changes in shares, stated capital and other items states that the total number of issued shares increased by 288,800 shares during the second quarter under review through the exercise of share acquisition rights, while stated capital and capital reserves each increased by ¥3.691 million. - FY2018AdvancedAnnual report
「20 November 2017: Paid public offering (offering through the bookbuilding method), issue price ¥2,200, underwriting price ¥2,024, amount transferred to capital ¥1,012. 14 December 2017: Paid third-party allotment capital increase in connection with the overallotment.」
The completion of capital raising through the public offering at the time of listing, including the third-party allotment capital increase in connection with the overallotment, is detailed. - FY2018-Q3First statedAnnual report
「The company received payment for a capital increase through a paid public offering using the bookbuilding method, with 20 November 2017 as the payment date.」
The public offering increased stated capital and capital reserves by ¥192.280 million each, while the payment for the shares offered in connection with the listing and other proceeds increased cash and deposits by ¥1,018 million.